200-401-985
antibody from Rockland Immunochemicals, Inc.
Targeting: AIFM1
AIF, AUNX1, CMTX4, DFNX5, NAMSD, PDCD8
Antibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations
- Immunohistochemistry [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 200-401-985 - Provider product page
- Provider
- Rockland Immunochemicals, Inc.
- Proper citation
- Rockland Cat#200-401-985, RRID:AB_2305316
- Product name
- Anti-Apoptosis Inducing Factor (AIF) (RABBIT) Antibody - 200-401-985
- Antibody type
- Polyclonal
- Vial size
- 100 µl
Submitted references Decreased expression of apoptosis-inducing factor in renal cell carcinoma is associated with poor prognosis and reduced postoperative survival.
Enhanced cytotoxicity in triple-negative and estrogen receptor‑positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel.
Wang Z, Yuan C, Huang Y, Liu Z, Yu X, Lv C, Su Z
Oncology letters 2019 Sep;18(3):2805-2812
Oncology letters 2019 Sep;18(3):2805-2812
Enhanced cytotoxicity in triple-negative and estrogen receptor‑positive breast adenocarcinoma cells due to inhibition of the transient receptor potential melastatin-2 channel.
Koh DW, Powell DP, Blake SD, Hoffman JL, Hopkins MM, Feng X
Oncology reports 2015 Sep;34(3):1589-98
Oncology reports 2015 Sep;34(3):1589-98
No comments: Submit comment
Supportive validation
- Submitted by
- Rockland Immunochemicals, Inc. (provider)
- Main image
- Experimental details
- Immunohistochemistry of AIF in human retina with AIF antibody at 10 µg/ml.
- Validation comment
- Immunohistochemistry